Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–13 of 13 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT07089199
- Conditions
- Anlotinib, NSCLC, Nab-paclitaxel, +1 more
- Locations
-
- Qilu Hospital of Shandong University Jinan, Shandong, China
NCT05167994
- Conditions
- Anlotinib, Extremity, Intensity-modulated Radiotherapy, +7 more
- Locations
-
- Radiotherapy Department of Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
NCT04278222
- Conditions
- Anlotinib, Digestive System Diseases, Digestive System Neoplasms, +9 more
- Locations
-
- Department of Medical Oncology, Shanghai Changzheng Hospital Shanghai, China
Not Yet Recruiting
Benmelstobart Plus Anlotinib Combined With SBRT for Patients With Hepatocellular Carcinoma Failing First-Line Targeted Therapy
NCT07537777
- Conditions
- Adenocarcinoma, Anlotinib, Benmelstobart, +14 more
- Locations
-
- Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China
Not Yet Recruiting
Neoadjuvant Therapy of Targeted Immunotherapy Combined With Chemotherapy for Locally Advanced HNSCC
NCT06699498
- Conditions
- Anlotinib, Carcinoma, Carcinoma, Squamous Cell, +9 more
- Locations
-
- The First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China
NCT06048315
- Conditions
- Anlotinib, EGFR Sensitive Mutation, Lung Cancer, +9 more
- Locations
-
Not specified
Not Yet Recruiting
Safety and Efficacy of Aumolertinib Combined With Anlotinib as 1st Line Treatment in Advanced Lung Cancer EGFR Mutation With TP53 Co-Mutation
NCT05778149
- Conditions
- Anlotinib, Aumolertinib, EGFR Activating Mutation, +2 more
- Locations
-
Not specified
NCT04271813
- Conditions
- Anlotinib, Chemo-free Therapy, Colonic Diseases, +14 more
- Locations
-
- Department of Medical Oncology, Shanghai Changzheng Hospital Shanghai, China
NCT04012619
- Conditions
- Anlotinib, Non-squamous Non-small-cell Lung Cancer
- Locations
-
- West China Hospital, Sichuan University Chengdu, Sichuan, China
NCT03936452
- Conditions
- Anlotinib, Early Stage, Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type, +5 more
- Locations
-
- Sun Yat-Sen University Cancer Center Guangzhou, Guangdong, China
NCT04002284
- Conditions
- Anlotinib, Antineoplastic Agents, Breast Diseases, +6 more
- Locations
-
- National Cacner Center/ Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, Beijing Municipality, China
Active, Not Recruiting
Neoadjuvant PD-1 Inhibitor (Sintilimab), Anlotinib Combined With Chemotherapy in Resectable Stage IIA-IIIB NSCLC
NCT05400070
- Conditions
- Anlotinib, Chemotherapy, Lung Cancer, +8 more
- Locations
-
- Tangdu Hospital, the Air Force Military University Xi'an, China
Active, Not Recruiting
Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer
NCT04807166
- Conditions
- Adnexal Diseases, Angiogenesis, Anlotinib, +22 more
- Locations
-
- Huai'an First People's Hospital Huai'an, China
- Nanjing Drum Tower Hospital Nanjing, China
- Zhongda Hospital Southeast University Nanjing, China
- The First Affiliated Hospital of Soochow University Suzhou, China